Interaction of Cyclosporine A and the Renin-Angiotensin System New Perspectives
Journal:
Current Drug Metabolism
Volume:
3
Page:
61-71
Author(s):
M. Lassila
Genetic Engineering in Allotransplantation of Vascularized Organs
Journal:
Current Gene Therapy
Volume:
2
Page:
9-21
Author(s):
P. Mathieu, C. Chauveau, D. Bouchet, C. Guillot, L. Tesson and I. Anegon
Alzheimers Disease: Targets For Drug Development
Journal:
Mini-Reviews in Medicinal Chemistry
Volume:
2
Page:
1-9
Author(s):
Andrew J. Larner
Subject Index To Volume 7
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
85-97
Author(s):
Science Publishers Bentham
Thrombin Activable Fibrinolysis Inhibitor (TAFI): Molecular Genetics of an Emerging Potential Risk Factor for Thrombotic Disorders
Journal:
Current Drug Targets - Cardiovascular & Hematological Disorders
Volume:
1
Page:
59-74
Author(s):
M. B. Boffa, M. E. Nesheim and M. L. Koschinsky
Angiogenesis and Angiogenesis Inhibitors: a New Potential Anticancer Therapeutic Strategy
Journal:
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume:
1
Page:
241-253
Author(s):
G. Ranieri and G. Gasparini
The Use of Radioactive Iodine in the Management of Hyperthyroidism in Children
Journal:
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume:
1
Page:
255-264
Author(s):
Scott A. Rivkees
Tumor Bone Diseases: Molecular Mechanisms and Opportunities for Novel Treatments
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
1
Page:
313-329
Author(s):
Mira Susa, Markus Glatt and Anna Teti
Elucidating Neuronal and Vascular Injury Through the Cytoprotective Agent Nicotinamide
Journal:
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume:
1
Page:
257-267
Author(s):
Kenneth Maiese, Shi-Hua Lin and Zhao Zhong Chong
Therapeutic Prospects for Parathyroid Hormone and Parathyroid Hormone Analogs
Journal:
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume:
1
Page:
269-287
Author(s):
P. Morley, J.F. Whitfield and G.E. Willick